Search Results

Business

InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board

InteRNA Technologies, a clinical-stage biotech company developing microRNA -based therapeutics with a focus on cancer, announced the establishment of a Clinical Advisory Board and the appointment of new members to its Scientific Advisory Board.

October 19, 2021

·

7 min read

Business

InteRNA Appoints Established Oncology Innovator Andrea van Elsas, PhD, to its Supervisory Board

InteRNA Technologies, a clinical-stage biotech company developing microRNA -based therapeutics with a focus on cancer, announced the appointment of Andrea van Elsas, PhD, as a new member of the Company’s Supervisory Board.

October 12, 2021

·

4 min read

Drug Development

InteRNA Technologies Announces U.S. FDA Clearance of IND Application for Phase I Clinical Trial with Lead microRNA Candidate INT-1B3 in Patients with Advanced Solid Tumors

InteRNA Technologies announced it received Investigational New Drug clearance from the U.S. Food and Drug Administration for the company’s Phase I clinical trial evaluating lead miRNA candidate, INT-1B3, in patients with advanced solid tumors.

December 2, 2021

·

4 min read

InteRNA Technologies Awarded € 2.7M Clinical Innovation Credit from Dutch Government

InteRNA Technologies, a clinical-stage biotech company developing microRNA -based therapeutics with a focus on cancer, announced that it was awarded a Clinical Innovation Credit of € 2.7 Million from the Dutch government.

March 11, 2021

·

3 min read

InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors

InteRNA Technologies announced that the first patient has been dosed in the first cohort of its first-in-human Phase I study with the Company’s lead microRNA candidate, INT-1B3.

February 16, 2021

·

3 min read

Press Releases

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

November 21, 2024

·

7 min read

BioMidwest

Silq Technologies Receives Innovative Technology Contract From Vizient for ClearTract® Foley Catheter

Silq Technologies announced its ClearTract® Foley Catheter has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.

June 13, 2024

·

3 min read

Business

Xironetic Appoints Jeff Potts to Chief Technology Officer

Xironetic, a provider of augmented reality surgical guidance technology, is announcing the appointment of Jeff Potts to Chief Technology Officer.

June 19, 2024

·

2 min read

Business

Spineart Appoints Laurent Nodé-Langlois as Chief Technology Officer to Lead Enabling Technologies Business Unit

Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer.

June 28, 2024

·

2 min read

Press Releases

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

October 31, 2024

·

8 min read